The global relapsed or refractory diffuse large B-cell lymphoma market is rapidly gaining momentum owing to technological advancements in immunotherapy. Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin's lymphoma. It occurs when abnormal B-lymphocytes grow uncontrolled and crowd out normal cells of the immune system. Relapsed or refractory DLBCL refers to the...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek